Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y008077 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y008077 | — |
2 doses of MMRII were administered to a 4 year old patient at the same time; No additional AE; 2 doses of MMRII were administered to a 4 year old patient at the same time; This spontaneous report was received from a nurse and refers to a 4-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-Oct-2025, the patient was vaccinated with two doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) 0.5 mL (lot #Y008077 and valid expiration date reported as: 19-Apr-2026) administered for prophylaxis. The vaccines were reconstituted with sterile diluent, solution for injection (lot # and expiration date not reported). Therefore, two doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) were administered to a 4 year old patient at the same time (extra dose administered; inappropriate schedule of product administration). The vaccine coordinator stated that the patient had not experienced any clinical side effects at this time. The patients mother confirmed that no clinical side effects were reported. No additional adverse event (AE)and no product quality complaint (PQC) was noted.
sterile diluent